#pharmaceutical-market

[ follow ]
#ozempic #novo-nordisk #obesity-drugs #glp-1-drugs #obesity-rates #ma
Medicine
from24/7 Wall St.
6 days ago

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (Nov 2025)

Novo Nordisk's Ozempic and Wegovy sales have propelled the company to a valuation exceeding Denmark's GDP and spurred development of additional obesity drugs.
Medicine
fromFortune
3 weeks ago

Adult obesity rate fell from record high-and big pharma is reaping the benefits from mainstream sales of weight-loss drugs like Zepound and Mounjaro | Fortune

Rapid GLP-1 adoption has helped US adult obesity fall to 37%, driving substantial pharmaceutical revenue growth and fierce competition for weight-loss drugs.
[ Load more ]